(Q40854583)

24 September 2017

title

Sulfated fibroin, a novel sulfated peptide derived from silk, inhibits human immunodeficiency virus replication in vitro (English)

1 reference

24 September 2017

Gotoh K

1

1 reference

24 September 2017

Izumi H

2

1 reference

24 September 2017

Kanamoto T

3

1 reference

24 September 2017

Tamada Y

4

1 reference

24 September 2017

Nakashima H

5

1 reference

24 September 2017

language of work or name

1 reference

1 August 2000

1 reference

Bioscience, Biotechnology, and Biochemistry

24 September 2017

published in

1 reference

24 September 2017

volume

64

1 reference

24 September 2017

issue

8

1 reference

24 September 2017

page(s)

1664-1670

1 reference

In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1271%2FBBB.64.1664

Sulfation of the immunomodulating polysaccharide lentinan: A novel strategy for antivirals to human immunodeficiency virus (HIV)

21 January 2018

1 reference

https://api.crossref.org/works/10.1271%2FBBB.64.1664

Mechanism of the inhibitory effect of curdlan sulfate on HIV-1 infection in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1271%2FBBB.64.1664

Oral dextran sulfate (UA001) in the treatment of the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1271%2FBBB.64.1664

Dextran sulfate is poorly absorbed after oral administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1271%2FBBB.64.1664

Pharmacokinetics, toxicity, and activity of intravenous dextran sulfate in human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1271%2FBBB.64.1664

Anti-human immunodeficiency virus activity of a novel synthetic peptide, T22 ([Tyr-5,12, Lys-7]polyphemusin II): a possible inhibitor of virus-cell fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1271%2FBBB.64.1664

Human immunodeficiency virus (HIV)-induced cell fusion: Quantification and its application for the simple and rapid screening of anti-HIV substances in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1271%2FBBB.64.1664

Sulfated pentagalloyl glucose (Y-ART-3) inhibits HIV replication and cytopathic effects in vitro, and reduces HIV infection in hu-PBL-SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1271%2FBBB.64.1664

The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1271%2FBBB.64.1664

A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors

21 January 2018

1 reference

https://api.crossref.org/works/10.1271%2FBBB.64.1664

The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1271%2FBBB.64.1664

The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1271%2FBBB.64.1664

Change in coreceptor use correlates with disease progression in HIV-1--infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1271%2FBBB.64.1664

Identification of a major co-receptor for primary isolates of HIV-1

21 January 2018

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/381661A0

Identifiers

DOI

10.1271/BBB.64.1664

1 reference

24 September 2017

1 reference